SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 107.81   3.10 (+2.96%) Volume: 250.75k 4:00 PM EDT Oct 15, 2019
Filing Type:
Form TypeForm DescriptionPagesDateView
8-A12GRegistration of securities [Section 12(g)]6709/30/1996
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans5209/27/1996
S-3Registration statement under Securities Act of 19338709/25/1996
10-QGeneral form for quarterly reports under Section 13 or 15(d)5808/14/1996
10-QGeneral form for quarterly reports under Section 13 or 15(d)1105/09/1996
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals302/06/1996
SC 13D/A[Amend] General statement of acquisition of beneficial ownership312/22/1994
SC 13DGeneral statement of acquisition of beneficial ownership409/13/1994
9899100101102103104105106107108109110111112
Next
>
Last
�>>